Company: HSDTW
Filing Date: 2025-10-21
Form Type: 8-K
Source: 0001104659-25-100920
Chunk: 0

Company: Solana Co
Filing Date: 2025-10-21
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

On October 20, 2025, Solana Company (formerly known as Helius Medical Technologies, Inc.) (the “ Company”) issued a press release. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Information contained on or accessible through any website reference in the press release is not part of, or incorporated by reference in, this report, and the inclusion of such website addresses in this report by incorporation by reference of the press release is as inactive textual references only.

Exhibit 99.1 hereto contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are based on current expectations and are not guarantees of future performance. Further, the forward-looking statements are subject to the limitations listed in Exhibit 99.1 and in the other reports of the Company filed with the Securities and Exchange Commission, including that actual events or results may differ materially from those in the forward-looking statements.

The information in this report, including Exhibit 99.1 hereto, is furnished pursuant to Item 7.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. The Company’s submission of this report shall not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.

  Item 9.01      Financial Statements and Exhibits.  

(d) Exhibits

  Exhibit No.      Description                                                               
         99.1      Press Release, dated October 20, 2025.                                    
 ─────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               SOLANA COMPANY.                          
  Dated: October 20, 2025      By:                  /s/ Joseph Chee     
                                                    Joseph Chee         
                                                    Executive Chairman